You are here

  • Home
  • Archive
  • Volume 8, Issue 2
  • Tumor infiltrating lymphocytes (TIL) therapy in metastatic melanoma: boosting of neoantigen-specific T cell reactivity and long-term follow-up

Article metrics

Article menu

Download PDFPDF

XML
Clinical/translational cancer immunotherapy
Original research
Tumor infiltrating lymphocytes (TIL) therapy in metastatic melanoma: boosting of neoantigen-specific T cell reactivity and long-term follow-up

 

Online download statistics by month:

Online download statistics by month: August 2020 to October 2025

AbstractFullPdf
Aug 2020686683317
Sep 2020335335159
Oct 202032232297
Nov 202026827180
Dec 2020377377109
Jan 2021547547123
Feb 2021666666130
Mar 2021845845167
Apr 2021807807167
May 2021655655169
Jun 2021591591155
Jul 2021423423129
Aug 202132532599
Sep 2021285285130
Oct 2021289289147
Nov 2021309310155
Dec 2021269271110
Jan 202221122290
Feb 2022222234108
Mar 2022383409167
Apr 2022422443138
May 2022306314144
Jun 202224826987
Jul 202219720573
Aug 2022187192139
Sep 2022367377142
Oct 2022389402123
Nov 2022512514131
Dec 2022895898143
Jan 2023516519100
Feb 2023647656138
Mar 2023821831140
Apr 2023825835130
May 2023503515116
Jun 202345947395
Jul 2023690694124
Aug 202356958696
Sep 202349649884
Oct 202343544590
Nov 2023586595106
Dec 202342042392
Jan 202419019184
Feb 2024825827130
Mar 2024657671199
Apr 2024541552142
May 2024436444106
Jun 2024373379100
Jul 202443243883
Aug 202438238882
Sep 202429029285
Oct 2024376378122
Nov 2024387394100
Dec 202436437675
Jan 202534334891
Feb 2025419422106
Mar 202529730093
Apr 202530430468
May 202525926164
Jun 202515115828
Jul 2025110
Sep 2025110
Oct 2025110
Total26334266776997